Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action

FASEB Journal

Volumn 13, Issue 11, 1999, Pages 1347-1357

  Gardin, Anne ^a   Auzan, Colette ^b   Clauser, Eric ^b   Malherbe, Tatiana ^a   Aunis, Dominique ^a   Crémel, Gérard ^a   Hubert, Pierre ^a  

^a INSERM   (France)

^b l'alimentation et l'Environnement   (France)

Author keywords

Receptor dimerization; Signaling; Transfection of chimeric receptors; Tyrosine phosphorylation

Indexed keywords

COMPLEMENTARY DNA; GLYCOPHORIN A; INSULIN; INSULIN RECEPTOR;

ARTICLE; CHO CELL; CONTROLLED STUDY; DNA SEQUENCE; ELECTROPHORESIS; GENETIC TRANSFECTION; INSULIN BINDING; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 0032815374     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.11.1347     Document Type: Article

References (42)

1. Kahn, C. R., White, M. F., Shoelson, S. E., Backer, J. M., Araki, E., Cheatham, B., Csermely, P., Folli, F., Goldstein, B. J., Huertas, P., et al. (1993) The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Prog. Horm. Res. 48, 291-339
2. Cheatham, B., and Kahn, C. R. (1995) Insulin action and the insulin signaling network. Endocr. Rev. 16, 117-142
3. Hubbard, S. R., Wei, L., Ellis, L., and Hendrickson, W. A. (1994) Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (London) 372, 746-754
4. Hubbard, S. R. (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16, 5572-5581
5. Frattali, A., Treadway, J., and Pessin, J. (1991) Evidence supporting a passive role for the insulin receptor transmembrane domain in insulin-dependent signal transduction. J. Biol. Chem. 266, 9829-9834
6. Li, S. C., Deber, C. M., and Shoelson, S. E. (1994) An irregularity in the transmembrane domain helix correlates with the rate of insulin receptor internalization. Biochemistry 33, 14333-14338
7. Whittaker, J., Garcia, P., Yu, G. Q., and Mynarcik, D. C. (1994) Transmembrane domain interactions are necessary for negative cooperativity of the insulin receptor. Mol. Endocrinol. 8, 1521-1526
8. Cheatham, B., Shoelson, S. E., Yamada, K., Goncalves, E., and Kahn, C. R. (1993) Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. Proc. Natl. Acad. Sci. USA 90, 7336-7340
9. Longo, N., Shuster, R. C., Griffin, L. D., Langley, S. D., and Elsas, L. J. (1992) Activation of insulin receptor signaling by a single amino acid substitution in the transmembrane domain. J. Biol. Chem. 267, 12416-12419
10. Yamada, K., Goncalves, E., Kahn, C. R., and Shoelson, S. E. (1992) Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro. J. Biol. Chem. 267, 12452-12461
11. Ullrich, A., and Schlessinger, J. (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212
12. Cadena, D. L., and Gill, G. N. (1992) Receptor tyrosine kinases. FASEB J. 6, 2332-2337
13. Lemmon, M. A., Flanagan, J. M., Treutlein, H. R., Zhang, J., and Engelman, D. M. (1992) Sequence specificity in the dimerization of transmembrane alpha-helices. Biochemistry 31, 12719-12725
14. Ellis, L., Clauser, E., Morgan, D., Edery, M., Roth, R., and Rutter, W. (1986) Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45, 721-732
15. Lemmon, M. A., Flanagan, J. M., Hunt, J. F., Adair, B. D., Bormann, B. J., Dempsey, C. E., and Engelman, D. M. (1992) Glycophorin-A dimerization is driven by specific interactions between transmembrane alpha-helices. J. Biol. Chem. 267, 7683-7689
16. Munson, P. J., and Rodbard, D. (1980) Ligand: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 220-239
17. Le Marchand-Brustel, Y., Ballotti, R., and Van Obberghen, E. (1988) Insulin receptor kinase activity in states with altered insulin action. In Insulin receptors, Part A (Kahn, C., and Harrison, L., eds) pp. 163-179, Alan R. Liss, N.Y.
18. Flörke, R. R., Klein, H. W., and Reinauer, H. (1990) Structural requirements for signal transduction of the insulin receptor. Eur. J. Biochem. 191, 473-482
19. Leconte, I., Auzan, C., Debant, A., Rossi, B., and Clauser, E. (1992) N-linked oligosaccharide chains of the insulin receptor-beta subunit are essential for transmembrane signalling. J. Biol. Chem. 267, 17415-17423
20. Meloche, S., Pages, G., and Pouyssegur, J. (1992) Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44mapk. Mol Biol. Cell 3, 63-71
21. Ruderman, N. B., Kapeller, R., White, M. F., and Cantley, L. C. (1990) Activation of phosphatidylinositol 3-kinase by insulin. Proc. Natl. Acad. Sci. USA 87, 1411-1415
22. Towbin, H., Staehelin, T., and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354
23. Ganderton, R. H., Stanley, K. K., Field, C. E., Coghlan, M. P., Soos, M. A., and Siddle, K. (1992) A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors. Biochem J. 288, 195-205
24. Debant, A., Clauser, E., Ponzio, G., Filloux, C., Auzan, C., Contreres, J., and Rossi, B. (1988) Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc. Natl. Acad. Sci. USA 85, 8032-8036
25. Lee, J., Pilch, P. F., Shoelson, S. E., and Scarlata, S. F. (1997) Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy. Biochemistry 36, 2701-2708
26. Lenwerder, K., Flörke, R.-R., Passlack, W., Wichert, M., and Reinauer, H. (1997) The significance of transmembrane and cytoplasmic segments for hormone induced conformational changes of the insulin receptor. Protein Sci. 6 (Suppl. 1), 107 (abstr.)
27. Bargmann, C. I., Hung, M. C., and Weinberg, R. A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45, 649-657
28. Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V., and Greene, M. I. (1989) A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (London) 339, 230-231
29. Shiang, R., Thompson, L. M., Zhu, Y. Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., and Wasmuth, J. J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335-342
30. Rousseau, F., Bonaventure, J., Legeai, M. L., Pelet, A., Rozet, J. M., Maroteaux, P., Le Merrer, M., and Munnich, A. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (London) 371, 252-254
31. Webster, M. K., and Donoghue, D. J. (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520-527
32. Xiong, Q. H., Chan, J. L. K., Zong, C. S., and Wang, L. H. (1996) Two chimeric receptors of epidermal growth factor receptor and c-ros that differ in their transmembrane domains have opposite effects on cell growth. Mol. Cell. Biol. 16, 1509-1518
33. Kim, H., and Baumann, H. (1997) Transmembrane Domain of gp130 Contributes to Intracellular Signal Transduction in Hepatic Cells. J. Biol. Chem. 272, 30741-30747
34. Miloso, M., Mazzotti, M., Vass, W. C., and Beguinot, L. (1995) SHC and GRB-2 are constitutively activated by an epidermal growth factor receptor with a point mutation in the transmembrane domain. J. Biol. Chem. 270, 19557-19562
35. Takahashi, K., Yonezawa, K., and Nishimoto, I. (1995) Insulin-like growth factor I receptor activated by a transmembrane mutation. J. Biol. Chem. 270, 19041-19045
36. Petti, L. M., Irusta, P. M., and DiMaio, D. (1998) Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu*. Oncogene 16, 843-851
37. MacKenzie, K. R., Prestegard, J. H., and Engelman, D. M. (1997) A transmembrane helix dimer: structure and implications. Science 276, 131-133
38. MacKenzie, K. R., and Engelman, D. M. (1998) Structure-based prediction of the stability of transmembrane helix-helix interactions: The sequence dependence of glycophorin A dimerization. Proc. Natl. Acad. Sci. USA 95, 3583-3590
39. Langosch, D., Brosig, B., Kolmar, H., and Fritz, H. J. (1996) Dimerisation of the glycophorin A transmembrane segment in membranes probed with the ToxR transcription activator. J. Mol. Biol. 263, 525-530
40. Burke, C. L., Lemmon, M. A., Coren, B. A., Engelman, D. M., and Stern, D. F. (1997) Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene 14, 687-696
41. Garnier, N., Genest, D., Duneau, J. P., and Genest, M. (1997) Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains - stabilization by interhelical hydrogen bonds in the oncogenic form. Biopolymers 42, 157-168
42. Lee, J., Shoelson, S. E., and Pilch, P. F. (1995) Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity. J. Biol. Chem. 270, 31136-31140